Synergistic effects of probiotics and low-FODMAP diet on clinical and inflammatory outcomes in ulcerative colitis: a retrospective cohort study - Report - MDSpire
Advertisement
Synergistic effects of probiotics and low-FODMAP diet on clinical and inflammatory outcomes in ulcerative colitis: a retrospective cohort study
Clinical Report: Combined Impact of Probiotics and a Low-FODMAP Diet on UC
Overview
This study evaluates the combined effects of a low-FODMAP diet and probiotics on clinical and inflammatory outcomes in adults with mild-to-moderate ulcerative colitis (UC).
Background
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that significantly impacts patients' quality of life. Current treatment options often leave patients with incomplete remission.
Data Highlights
Group
Mayo Score Change
CRP Change (mg/L)
Clinical Remission (%)
FCal Change (μg/g)
Low-FODMAP + Probiotic
-2.4 ± 0.8
-3.5 ± 1.8
60
-180 ± 70
Key Findings
The combined low-FODMAP + probiotic group had the greatest reduction in Mayo score (−2.4 ± 0.8; p < 0.001).
CRP levels decreased significantly in the combined treatment group (−3.5 ± 1.8 mg/L).
60% of patients in the combined group achieved clinical remission.
Fecal calprotectin levels improved significantly in the combined group (−180 ± 70 μg/g).
Patients were stratified into four groups: low-FODMAP + probiotic, low-FODMAP only, probiotic only, and standard care.
Clinical Implications
The findings suggest that a combined low-FODMAP diet and probiotic regimen may be beneficial for patients with mild-to-moderate UC. Clinicians should consider this integrated approach as a potential adjunctive strategy in managing UC symptoms and inflammation.
Conclusion
Further research is warranted to confirm these findings and explore their underlying mechanisms.
